VistaGen Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Rok finansowy 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Przychód (mln) 0 0 0 0 1 0 0 0 0 1 0 0 0 1 1 -0 1 0
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% inf% -85.1% -100.0% 0.0% 0.0% inf% -100.0% 0.0% 0.0% inf% 1.8% -120.5% -568.1% -54.3%
Marża brutto 0.0% 0.0% 0.0% 0.0% 100.0% 100.0% 0.0% 0.0% 0.0% 100.0% 0.0% -inf% -inf% 100.0% 26.5% 324.3% 46.6% 100.0%
EBIT (mln) -0 -0 -0 -0 -9 -7 -5 -7 -18 -10 -14 -25 -21 -18 -48 -59 -33 -56
EBIT Δ r/r 0.0% 242.5% 34.1% -59.3% 100988.8% -24.9% -26.0% 34.8% 163.4% -42.6% 38.6% 72.9% -15.3% -13.8% 166.4% 23.9% -44.2% 69.5%
EBIT (%) 0.0% 0.0% 0.0% 0.0% -673.8% -3389.8% 0.0% 0.0% 0.0% -819.9% 0.0% 0.0% 0.0% -1646.1% -4308.7% 26040.7% -3103.5% -11517.1%
Koszty finansowe (mln) 0 0 0 0 2 1 2 5 1 0 0 -8 0 0 0 0 0 0
EBITDA (mln) -0 -0 -0 -0 -9 -7 -5 -7 -18 -10 -14 -24 -21 -18 -47 -59 -33 -55
EBITDA(%) 0.0% 0.0% 0.0% 0.0% -670.4% -3340.6% 0.0% 0.0% 0.0% -815.5% 0.0% 0.0% 0.0% -1633.9% -4221.8% 25816.5% -3103.5% -11386.4%
Podatek (mln) -0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Zysk Netto (mln) -0 -0 -0 -0 -12 -13 -3 -14 -47 -10 -14 -25 -21 -18 -48 -59 -29 -51
Zysk netto Δ r/r 0.0% 245.3% 34.0% -59.2% 135923.8% 5.5% -77.0% 367.9% 240.1% -78.3% 39.9% 71.4% -15.5% -13.7% 166.3% 24.0% -50.4% 75.1%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% -909.7% -6430.5% 0.0% 0.0% 0.0% -820.4% 0.0% 0.0% 0.0% -1646.1% -4307.2% 26065.9% -2759.2% -10579.8%
EPS 0.0 -0.95 -1.13 -0.46 -497.11 -764.72 -81.03 -315.87 -872.51 -46.3 0.0 -25.83 -14.21 -6.25 -7.24 -8.51 -1.52 -1.67
EPS (rozwodnione) 0.0 -0.95 -1.13 -0.46 -497.11 -764.72 -114.28 -318.27 -872.51 -46.3 0.0 -25.83 -14.21 -6.25 -7.24 -8.51 -1.52 -1.67
Ilośc akcji (mln) 0 0 0 0 0 0 0 0 0 0 0 1 1 3 7 7 19 31
Ważona ilośc akcji (mln) 0 0 0 0 0 0 0 0 0 0 0 1 1 3 7 7 19 31
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD